Treatment of neurodegenerative conditions

摘要

The use of a defined structure lipid glyceride comprising a glycerol moiety esterifed with one or more fatty acid moieties, characterised in that the lipid has a fatty acid moiety at the sn-2 position selected from the group consisting of q -linolenic acid and dihomo- q -linolenic acid for the manufacture of a medicament for the treatment of a neurodegenerative disease is provided characterised in that it is a lipid of formula II ```wherein

R<1> and R<3>

are the same and are selected from H, -C(O)(CH2)nCH3 wherein n is selected from 4 to 16, and

R<2>

is selected from q -linolenoyl and dihomo- q -linolenoyl-residues.

characterised in that the medicament is for daily dosing at between 1 and 20 grams of he lipid glyceride.